2000至2019年医疗保险乳房再造报销与利用的程序趋势
该研究分析2000至2019年美国医疗保险对15种常见乳房再造手术的报销趋势,按消费者价格指数调整至2019年美元。所有手术平均调整后报销下降13.32%,仅即刻植入乳房假体增加55.37%,最大平均降幅为其他技术乳房再造(-28.63%)。作者认为了解报销趋势对制定可接受的报销模型至关重要。
要点
- 2000至2019年,15种乳房再造手术平均调整后报销下降13.32%。
- 仅即刻植入乳房假体报销增加55.37%,其余手术均呈负增长。
- 最大平均降幅为其他技术乳房再造(-28.63%),其次为单蒂横行腹直肌肌皮瓣(-26.02%)。
核心结论
- 过去20年,大多数乳房再造手术的医疗保险报销持续且大幅下降。
- 鉴于医疗成本上升和美国医疗体系财务不确定性,了解报销趋势对政策制定者、管理者和医生制定可接受的报销模型至关重要。
研究设计与样本
- 利用美国医疗保险和医疗补助服务中心医师费用表查询工具,分析15种常见乳房再造手术各现行程序术语代码的报销数据。
- 通过美国消费者价格指数变化,将货币数据调整通胀至2019年美元。
- 使用通胀调整后趋势计算报销随时间的平均年度和总百分比变化。
主要发现
- 2000至2019年,所有手术平均调整后报销下降13.32%。
- 除即刻植入乳房假体增加55.37%外,所有手术调整后报销率均为负。
- 最大平均降幅为其他技术乳房再造(-28.63%),其次为单蒂横行腹直肌肌皮瓣(-26.02%)、单蒂横行腹直肌肌皮瓣伴微血管吻合(-23.33%)、背阔肌皮瓣(-19.65%)和游离皮瓣再造(-19.36%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Development of appropriate reimbursement models for breast reconstruction in the United States requires an understanding of relevant economic trends. The purpose of this study is to evaluate longitudinal patterns in Medicare reimbursement for frequently performed breast reconstruction procedures between 2000 and 2019. METHODS: Reimbursement data for 15 commonly performed breast reconstruction procedures were analyzed using the Centers for Medicare & Medicaid Services Physician Fee Schedule Look-Up Tool for each Current Procedural Terminology code. By utilizing changes to the US consumer price index, monetary data were adjusted for inflation to 2019 US dollars. Inflation-adjusted trends were used to calculate average annual and total percentage changes in reimbursement over time. RESULTS: From 2000 to 2019, average adjusted reimbursement for all procedures fell by 13.32%. All procedures demonstrated a negative adjusted reimbursement rate other than immediate insertion of breast prosthesis, which increased by 55.37%. The largest mean decrease was observed in breast reconstruction with other technique (-28.63%), followed by single pedicle transverse rectus abdominis myocutaneous flap (-26.02%), single pedicle transverse rectus abdominis myocutaneous flap with microvascular anastomosis (-23.33%), latissimus dorsi flap (-19.65%), and free flap reconstruction (-19.36%). CONCLUSIONS: There has been a steady yet substantial decline in Medicare reimbursement for the majority of breast reconstruction procedures over the last 20 years. Given increasing medical costs and the financial uncertainty of the US health care system, an understanding of Medicare reimbursement trends is vital for policymakers, administrators, and physicians to develop agreeable reimbursement models that facilitate growth and economic vitality of breast reconstruction in the United States.
引用
- Gupta N, Thornburg DA, Chow NA, et al. Procedural Trends in Medicare Reimbursement and Utilization for Breast Reconstruction: 2000-2019. Ann Plast Surg. 2022. PMID: 35234409. doi:10.1097/SAP.0000000000002830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。